Roxanne Quinn

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer.

S. Cannistra, N. Lindeman, U. Matulonis, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma

U. Matulonis, N. Horowitz, P. Konstantinopoulos, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.

E. Kohn, Su-Chun Cheng, G. Shapiro, 2020, The Lancet. Oncology.

Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.

Su-Chun Cheng, W. Barry, U. Matulonis, 2020, Gynecologic oncology.

A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma.

U. Matulonis, N. Horowitz, P. Konstantinopoulos, 2020 .

Qigong Mind-Body Exercise as a Biopsychosocial Therapy for Persistent Post-Surgical Pain in Breast Cancer: A Pilot Study

A. Giobbie-Hurder, P. Bonato, J. Ligibel, 2020, Integrative cancer therapies.